Literature DB >> 23320472

MLL2 mutation detection in 86 patients with Kabuki syndrome: a genotype-phenotype study.

P Makrythanasis1, B W van Bon, M Steehouwer, B Rodríguez-Santiago, M Simpson, P Dias, B M Anderlid, P Arts, M Bhat, B Augello, E Biamino, E M H F Bongers, M Del Campo, I Cordeiro, A M Cueto-González, I Cuscó, C Deshpande, E Frysira, L Izatt, R Flores, E Galán, B Gener, C Gilissen, S M Granneman, J Hoyer, H G Yntema, C M Kets, D A Koolen, C l Marcelis, A Medeira, L Micale, S Mohammed, S A de Munnik, A Nordgren, S Psoni, W Reardon, N Revencu, T Roscioli, M Ruiterkamp-Versteeg, H G Santos, J Schoumans, J H M Schuurs-Hoeijmakers, M C Silengo, L Toledo, T Vendrell, I van der Burgt, B van Lier, C Zweier, A Reymond, R C Trembath, L Perez-Jurado, J Dupont, B B A de Vries, H G Brunner, J A Veltman, G Merla, S E Antonarakis, A Hoischen.   

Abstract

Recently, pathogenic variants in the MLL2 gene were identified as the most common cause of Kabuki (Niikawa-Kuroki) syndrome (MIM#147920). To further elucidate the genotype-phenotype correlation, we studied a large cohort of 86 clinically defined patients with Kabuki syndrome (KS) for mutations in MLL2. All patients were assessed using a standardized phenotype list and all were scored using a newly developed clinical score list for KS (MLL2-Kabuki score 0-10). Sequencing of the full coding region and intron-exon boundaries of MLL2 identified a total of 45 likely pathogenic mutations (52%): 31 nonsense, 10 missense and four splice-site mutations, 34 of which were novel. In five additional patients, novel, i.e. non-dbSNP132 variants of clinically unknown relevance, were identified. Patients with likely pathogenic nonsense or missense MLL2 mutations were usually more severely affected (median 'MLL2-Kabuki score' of 6) as compared to the patients without MLL2 mutations (median 'MLL2-Kabuki score' of 5), a significant difference (p < 0.0014). Several typical facial features such as large dysplastic ears, arched eyebrows with sparse lateral third, blue sclerae, a flat nasal tip with a broad nasal root, and a thin upper and a full lower lip were observed more often in mutation positive patients.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Kabuki syndrome; MLL2; Niikawa-Kuroki syndrome; genotype-phenotype correlation

Mesh:

Substances:

Year:  2013        PMID: 23320472     DOI: 10.1111/cge.12081

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  24 in total

1.  Precocious chondrocyte differentiation disrupts skeletal growth in Kabuki syndrome mice.

Authors:  Jill A Fahrner; Wan-Ying Lin; Ryan C Riddle; Leandros Boukas; Valerie B DeLeon; Sheetal Chopra; Susan E Lad; Teresa Romeo Luperchio; Kasper D Hansen; Hans T Bjornsson
Journal:  JCI Insight       Date:  2019-10-17

Review 2.  Examining the impact of gene variants on histone lysine methylation.

Authors:  Capucine Van Rechem; Johnathan R Whetstine
Journal:  Biochim Biophys Acta       Date:  2014-05-23

3.  An Epigenetic Pathway Regulates Sensitivity of Breast Cancer Cells to HER2 Inhibition via FOXO/c-Myc Axis.

Authors:  Smita Matkar; Paras Sharma; Shubin Gao; Buddha Gurung; Bryson W Katona; Jennifer Liao; Abdul Bari Muhammad; Xiang-Cheng Kong; Lei Wang; Guanghui Jin; Chi V Dang; Xianxin Hua
Journal:  Cancer Cell       Date:  2015-10-12       Impact factor: 31.743

4.  A comparative analysis of KMT2D missense variants in Kabuki syndrome, cancers and the general population.

Authors:  Víctor Faundes; Geraldine Malone; William G Newman; Siddharth Banka
Journal:  J Hum Genet       Date:  2018-11-20       Impact factor: 3.172

Review 5.  Epigenetic control of the immune system: a lesson from Kabuki syndrome.

Authors:  Stefano Stagi; Anna Virginia Gulino; Elisabetta Lapi; Donato Rigante
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

6.  Identification of KMT2D and KDM6A mutations by exome sequencing in Korean patients with Kabuki syndrome.

Authors:  Chong Kun Cheon; Young Bae Sohn; Jung Min Ko; Yeoun Joo Lee; Ji Sun Song; Jea Woo Moon; Bo Kyoung Yang; Il Soo Ha; Eun Jung Bae; Hyun-Seok Jin; Seon-Yong Jeong
Journal:  J Hum Genet       Date:  2014-04-17       Impact factor: 3.172

Review 7.  Kabuki syndrome: review of the clinical features, diagnosis and epigenetic mechanisms.

Authors:  Yi-Rou Wang; Nai-Xin Xu; Jian Wang; Xiu-Min Wang
Journal:  World J Pediatr       Date:  2019-10-05       Impact factor: 2.764

8.  Near complete deletion of KMT2D in a college student.

Authors:  Catherine Gooch; Jaclyn Paige Souder; Matthew L Tedder; Jennifer Kerkhof; Jennifer A Lee; Raymond J Louie; Bekim Sadikovic; Robin S Fletcher; Nathaniel H Robin
Journal:  Am J Med Genet A       Date:  2022-01-18       Impact factor: 2.802

9.  The KMT2D Kabuki syndrome histone methylase controls neural crest cell differentiation and facial morphology.

Authors:  Karl B Shpargel; Cassidy L Mangini; Guojia Xie; Kai Ge; Terry Magnuson
Journal:  Development       Date:  2020-07-17       Impact factor: 6.862

10.  Bronchial isomerism in a Kabuki syndrome patient with a novel mutation in MLL2 gene.

Authors:  Gerarda Cappuccio; Alessandro Rossi; Paolo Fontana; Emma Acampora; Valeria Avolio; Giuseppe Merla; Leopoldo Zelante; Aurelio Secinaro; Generoso Andria; Daniela Melis
Journal:  BMC Med Genet       Date:  2014-01-28       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.